Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Alemtuzumab for the Treatment of Multiple Sclerosis
Revimmune (High-Dose Cyclophosphamide) for Autoimmune Diseases
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.
Genzyme’s LEMTRADA™ (alemtuzumab) application for MS accepted for review by the FDA
Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.
Determination and characterization of a cannabinoid receptor in rat brain.
Genzyme's Lemtrada™ Approved in Brazil for Treatment of Multiple Sclerosis
Normal Appearing and Diffusely Abnormal White Matter in Patients with Multiple Sclerosis Assessed with Quantitative MR.
Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
Receptos reports third quarter 2013 financial results
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study.
Copolymer-1 promotes neurogenesis and improves functional recovery after acute ischemic stroke in rats.
Glatiramer acetate, an anti-demyelination drug, reduced rats' epileptic seizures induced by pentylenetetrazol via protection of myelin sheath.
One calcitriol dose transiently increases Helios(+)FoxP3(+) T cells and ameliorates autoimmune demyelinating disease.
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Necrotizing skin lesion and radial nerve palsy in a patient treated with glatiramer acetate.
Intermittent self-catheterisation in MS.
Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.
Biogen Idec completes purchase of full rights and control of Tysabri®
Glatiramer Acetate 40 mg/mL in Relapsing-Remitting Multiple Sclerosis: A Review.
EMD Serono
Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
Receptos to deliver scientific presentations about RPC1063 at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.
Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.

Pages